Verano Holdings (VRNO) Cash from Financing Activities (2021 - 2026)

Verano Holdings (VRNO) reported Cash from Financing Activities of -$12.4 million for Q1 2026, down 1994.42% year-over-year from $653393.9 in Q1 2025, and down 230.61% quarter-over-quarter from -$3.7 million in Q4 2025.

Verano Holdings (VRNO) Cash from Financing Activities (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Cash from Financing Activities data on file, last reported at -$12.4 million in Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at -$12.4 million, down 1994.42% year-over-year; the trailing twelve-month figure through Mar 2026 was -$37.1 million (up 42.2% YoY), and the FY2025 annual result was -$25.3 million, up 61.59% from the prior year.
  • Cash from Financing Activities slipped to -$12.4 million in Q1 2026 per VRNO's latest filing, from -$3.7 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $92.8 million in Q1 2022 and troughed at -$53.2 million in Q2 2024.
  • A 5-year average of $586705.9 and a median of -$2.3 million in 2024 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2023 and 2026: Cash from Financing Activities surged 975.57% in 2023, then slumped 1994.42% in 2026.
  • A 5-year view of Cash from Financing Activities shows it stood at $2.1 million in 2022, then surged by 975.57% to $22.3 million in 2023, then plunged by 137.15% to -$8.3 million in 2024, then surged by 54.84% to -$3.7 million in 2025, then plunged by 230.61% to -$12.4 million in 2026.
  • Business Quant data shows VRNO's Cash from Financing Activities at -$12.4 million in Q1 2026, -$3.7 million in Q4 2025, and -$4.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 13.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1.48 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -86.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.47 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -77.88 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -11.62 Mn
10 Verano Holdings - - 98.98 Mn -12.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -12.38 Mn
Mar 31, 2026 -12.38 Mn
Dec 31, 2025 -3.74 Mn
Dec 31, 2025 -3.74 Mn
Sep 30, 2025 -4.85 Mn
Sep 30, 2025 -4.85 Mn
Jun 30, 2025 -16.14 Mn
Jun 30, 2025 -16.14 Mn
Mar 31, 2025 -591,000.00
Mar 31, 2025 -591,000.00
Dec 31, 2024 -8.29 Mn
Dec 31, 2024 -8.29 Mn
Sep 30, 2024 -2.17 Mn
Sep 30, 2024 -2.17 Mn
Jun 30, 2024 -53.15 Mn
Jun 30, 2024 -53.15 Mn
Mar 31, 2024 -2.32 Mn
Mar 31, 2024 -2.32 Mn
Dec 31, 2023 22.32 Mn
Dec 31, 2023 22.32 Mn